Chapter 75 Malignant Effusions

  1. Brisson BA, Reggeti F, Bienzle D: Portal site metastasis of invasive mesothelioma after diagnostic thoracoscopy in a dog, J Am Vet Med Assoc 229:980, 2006. PUBMED Abstract
  2. Charney SC et al: Evaluation of intracavitary mitoxantrone and carboplatin for treatment of carcinomatosis, sarcomatosis and mesothelioma, with or without malignant effusions: a retrospective analysis of 12 cases (1997-2002), Vet Comp Oncol 3:171, 2005. PUBMED Abstract
  3. Chu CM et al: The role of laparoscopy in the evaluation of ascites of unknown origin, Gastrointest Endosc 40:285, 1994. PUBMED Abstract
  4. Clifford CA et al: Vascular endothelial growth factor concentrations in body cavity effusions in dogs, J Vet Intern Med 16:164, 2002. PUBMED Abstract
  5. Hawkins EC, Fossum TW: Pleural effusion. In Bonagura JD, Twedt DC, editors: Kirk's current veterinary therapy XIV, St Louis, 2009, Saunders, p 675.
  6. Kobold S et al: Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites? Oncologist 14:1242, 2009. PUBMED Abstract
  7. Lind MJ et al: Comparative intraperitoneal pharmacokinetics of three platinum analogues, Cancer Chemother Pharmacol 28:315, 1991. PUBMED Abstract
  8. Luo JC, Toyoda M, Shibuya M: Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody, Cancer Res 58:2594, 1998. PUBMED Abstract
  9. Moore AS, Kirk C, Cardona A: Intracavitary cisplatin chemotherapy experience with six dogs, J Vet Intern Med 5:227, 1991. PUBMED Abstract
  10. Rudlowski C et al: Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up, Int J Gynecol Cancer 16(Suppl 1):183, 2006. PUBMED Abstract
  11. Smeak DD et al: Treatment of chronic pleural effusion with pleuroperitoneal shunts in dogs: 14 cases (1985-1999), J Am Vet Med Assoc 219:1590, 2001. PUBMED Abstract